The objective of this report is to assess the current landscape of federal and federally funded health care data relevant to PCOR and economic analysis to identify gaps for data stewards, researchers, and future collection efforts.
Biomedical Research & Development
Reports
Displaying 1 - 3 of 3. 10 per page. Page 1.
Advanced SearchReport
Federal Data for Conducting Patient-Centered Outcomes Research on Economic Outcomes
September 29, 2021
Cost Drivers in the Development and Validation of Biomarkers Used in Drug Development
October 23, 2018
Despite the increasing investment and interest in drug development, the amount of time and resources needed to develop a new drug continues to rise. Biomarkers are an important tool with the potential to decrease the time, cost, and failure rate of drug development.
Personalized Health Care Expert Panel Meeting: Summary Report
September 9, 2007
Contents Demonstrating Clinical Validity and Utility Demonstrating Value Reducing Health Disparities Educating and Engaging Providers and Consumers Using Databases to Build Eviden